iron mountain inc. - IRM
IRM
Close Chg Chg %
95.80 0.44 0.46%
Closed Market
96.24
+0.44 (0.46%)
Volume: 911.09K
Last Updated:
May 23, 2025, 3:59 PM EDT
Company Overview: iron mountain inc. - IRM
IRM Key Data
| Open $95.40 | Day Range 95.18 - 96.42 |
| 52 Week Range 72.33 - 130.24 | Market Cap $28.27B |
| Shares Outstanding 295.04M | Public Float 292.71M |
| Beta 1.10 | Rev. Per Employee N/A |
| P/E Ratio 233.49 | EPS $0.42 |
| Yield 299.06% | Dividend $0.79 |
| EX-DIVIDEND DATE Jun 16, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.56M |
IRM Performance
| 1 Week | -4.37% | ||
| 1 Month | 9.68% | ||
| 3 Months | 3.26% | ||
| 1 Year | 19.92% | ||
| 5 Years | 298.06% |
IRM Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
10
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 112.333 | |
| Number of Ratings | 10 | Current Quarters Estimate | 0.50 | |
| FY Report Date | 06 / 2025 | Current Year's Estimate | 1.993 | |
| Last Quarter’s Earnings | 0.43 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.77 | Next Fiscal Year Estimate | 2.333 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 6 | 6 | 7 | 7 |
| Mean Estimate | 0.50 | 0.54 | 1.99 | 2.33 |
| High Estimates | 0.59 | 0.63 | 2.29 | 2.69 |
| Low Estimate | 0.43 | 0.47 | 1.68 | 2.05 |
| Coefficient of Variance | 11.86 | 10.75 | 10.72 | 10.61 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 7 | 6 | 6 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 1 | 1 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 1 | 1 | 1 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Iron Mountain Inc. - IRM
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Iron Mountain Inc. - IRM
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Apr 8, 2025 | Robin L. Matlock Director | 983 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 8, 2025 | Doyle R. Simons Director | 41,033 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 8, 2025 | Doyle R. Simons Director | 41,432 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 8, 2025 | Clarke H. Bailey Director | 90,861 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 8, 2025 | Theodore Rapp Samuels Director | 7,376 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 8, 2025 | Theodore Rapp Samuels Director | 7,444 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | William Meaney President and CEO; Director | 217,620 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $90.3 per share | 19,651,086.00 |
| Mar 6, 2025 | William Meaney President and CEO; Director | N/A | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $90 per share | 0.00 |
| Mar 6, 2025 | William Meaney President and CEO; Director | 6,806 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $89.24 per share | 607,367.44 |
| Mar 6, 2025 | William Meaney President and CEO; Director | 68,088 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $88.35 per share | 6,015,574.80 |
| Mar 6, 2025 | William Meaney President and CEO; Director | 168,277 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $92.34 per share | 15,538,698.18 |
| Mar 6, 2025 | William Meaney President and CEO; Director | 177,877 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $91.62 per share | 16,297,090.74 |
| Jan 6, 2025 | Michelle Vervais Altamura EVP, General Counsel, Sec. | 2,428 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jan 6, 2025 | June Yee Felix Director | 742 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $105.11 per share | 77,991.62 |
| Jan 6, 2025 | Michelle Vervais Altamura EVP, General Counsel, Sec. | 3,031 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $104.74 per share | 317,466.94 |
| Jan 6, 2025 | Michelle Vervais Altamura EVP, General Counsel, Sec. | 3,500 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Aug 9, 2024 | Kent P. Dauten Director | 1,405,432 | Bona fide gift | 0.00 |
| Jul 25, 2024 | Andre Maciel Director | 1,627 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $100.13 per share | 162,911.51 |
| Jul 18, 2024 | John Tomovcsik EVP, Chief Operating Officer | 17,866 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $100 per share | 1,786,600.00 |
| Jun 25, 2024 | John Tomovcsik EVP, Chief Operating Officer | 20,366 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $89.42 per share | 1,821,127.72 |